77 related articles for article (PubMed ID: 3841695)
21. Anticonvulsant and related effects of U-54494A in various seizure tests.
Fischer W; Bodewei R; VonVoigtlander PF; Müller M
J Pharmacol Exp Ther; 1993 Oct; 267(1):163-70. PubMed ID: 8229743
[TBL] [Abstract][Full Text] [Related]
22. Preclinical evaluation of PNU-151774E as a novel anticonvulsant.
Fariello RG; McArthur RA; Bonsignori A; Cervini MA; Maj R; Marrari P; Pevarello P; Wolf HH; Woodhead JW; White HS; Varasi M; Salvati P; Post C
J Pharmacol Exp Ther; 1998 May; 285(2):397-403. PubMed ID: 9580576
[TBL] [Abstract][Full Text] [Related]
23. 2-phosphonomethyl-pentanedioic acid (glutamate carboxypeptidase II inhibitor) increases threshold for electroconvulsions and enhances the antiseizure action of valproate against maximal electroshock-induced seizures in mice.
Luszczki JJ; Mohamed M; Czuczwar SJ
Eur J Pharmacol; 2006 Feb; 531(1-3):66-73. PubMed ID: 16403497
[TBL] [Abstract][Full Text] [Related]
24. Pharmacological and biochemical evaluation of triethyltin's anticonvulsant effects.
Fox DA
Neurobehav Toxicol Teratol; 1982; 4(2):273-8. PubMed ID: 6283410
[TBL] [Abstract][Full Text] [Related]
25. Central nervous system pharmacology of propranolol.
Iyer KS; Govindankutty A; Radha M
Indian J Physiol Pharmacol; 1975; 19(3):152-6. PubMed ID: 1205559
[TBL] [Abstract][Full Text] [Related]
26. Catecholaminergic influences on induced hippocampal paroxysmal activity in rats.
de Campos CJ; Cavalheiro EA
Acta Physiol Pharmacol Latinoam; 1986; 36(3):233-49. PubMed ID: 3577804
[TBL] [Abstract][Full Text] [Related]
27. Trace amines inhibit the electrically evoked release of [3H]acetylcholine from slices of rat striatum in the presence of pargyline: similarities between beta-phenylethylamine and amphetamine.
Baud P; Arbilla S; Cantrill RC; Scatton B; Langer SZ
J Pharmacol Exp Ther; 1985 Oct; 235(1):220-9. PubMed ID: 3930699
[TBL] [Abstract][Full Text] [Related]
28. Convulsive thresholds and the activity of anticonvulsants in electroseizure test. The role of serotoninergic system.
Przegaliński E
Pol J Pharmacol Pharm; 1976; 28(2):143-55. PubMed ID: 934946
[TBL] [Abstract][Full Text] [Related]
29. The effect of propranolol on maximal electroshock seizures in mice.
Akkan AG; Yillar DO; Eşkazan E; Akcasu A; Ozüner Z
Int J Clin Pharmacol Ther Toxicol; 1989 May; 27(5):255-7. PubMed ID: 2737792
[TBL] [Abstract][Full Text] [Related]
30. Furosemide potentiates the anticonvulsant action of valproate in the mouse maximal electroshock seizure model.
Luszczki JJ; Sawicka KM; Kozinska J; Borowicz KK; Czuczwar SJ
Epilepsy Res; 2007 Aug; 76(1):66-72. PubMed ID: 17659862
[TBL] [Abstract][Full Text] [Related]
31. Tramadol, a centrally acting opioid: anticonvulsant effect against maximal electroshock seizure in mice.
Manocha A; Sharma KK; Mediratta PK
Indian J Physiol Pharmacol; 1998 Jul; 42(3):407-11. PubMed ID: 9741657
[TBL] [Abstract][Full Text] [Related]
32. Effect of propranolol on brain electrical activity during hyperbaric oxygenation in the rat.
Torbati D
Undersea Biomed Res; 1985 Dec; 12(4):423-9. PubMed ID: 4082345
[TBL] [Abstract][Full Text] [Related]
33. The effects of propranolol stereoisomers on nomotopic and ectopic cardiac automaticity in the rat.
Roman E; Ruiz F; Perez D; Hernández J
Res Commun Chem Pathol Pharmacol; 1987 Oct; 58(1):139-42. PubMed ID: 3432731
[TBL] [Abstract][Full Text] [Related]
34. The maximal electroshock seizure (MES) model in the preclinical assessment of potential new antiepileptic drugs.
Castel-Branco MM; Alves GL; Figueiredo IV; Falcão AC; Caramona MM
Methods Find Exp Clin Pharmacol; 2009 Mar; 31(2):101-6. PubMed ID: 19455265
[TBL] [Abstract][Full Text] [Related]
35. Anticonvulsant properties of the novel nootropic agent nefiracetam in seizure models of mice and rats.
Kitano Y; Komiyama C; Makino M; Takasuna K; Takazawa A; Sakurada S
Epilepsia; 2005 Jun; 46(6):811-8. PubMed ID: 15946322
[TBL] [Abstract][Full Text] [Related]
36. Comparison of the effects of anticonvulsant drugs with diverse mechanisms of action in the formalin test in rats.
Shannon HE; Eberle EL; Peters SC
Neuropharmacology; 2005 Jun; 48(7):1012-20. PubMed ID: 15857628
[TBL] [Abstract][Full Text] [Related]
37. Anticonvulsant activity of the linalool enantiomers and racemate: investigation of chiral influence.
de Sousa DP; Nóbrega FF; Santos CC; de Almeida RN
Nat Prod Commun; 2010 Dec; 5(12):1847-51. PubMed ID: 21299105
[TBL] [Abstract][Full Text] [Related]
38. Design, synthesis, and anticonvulsant activity of N-phenylamino derivatives of 3,3-dialkyl-pyrrolidine-2,5-diones and hexahydro-isoindole-1,3-diones.
Kamiński K; Obniska J
Bioorg Med Chem; 2008 May; 16(9):4921-31. PubMed ID: 18375131
[TBL] [Abstract][Full Text] [Related]
39. 3-Sulfamoylmethyl-1,2-benzisoxazole, a new type of anticonvulsant drug. Pharmacological profile.
Masuda Y; Karasawa T; Shiraishi Y; Hori M; Yoshida K; Shimizu M
Arzneimittelforschung; 1980; 30(3):477-83. PubMed ID: 7387759
[TBL] [Abstract][Full Text] [Related]
40. Protective effects of different beta-blocking agents against electroshock lethality in mice.
Pérez-Ojeda E; Hernandez J; Serrano JS
J Pharmacol; 1983; 14(3):303-9. PubMed ID: 6138460
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
